JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1677/joe.0.1750251

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karssen, A.
Right arrow Articles by De Kloet, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karssen, A.
Right arrow Articles by De Kloet, E.
Journal of Endocrinology, Vol 175, Issue 1, 251-260
Copyright © 2002 by Society for Endocrinology


Articles

The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone

AM Karssen, OC Meijer, IC van der Sandt, AG De Boer, EC De Lange, and ER De Kloet


In the present study, we have investigated the role of the multidrug resistance (mdr) P-glycoprotein (Pgp) at the blood-brain barrier in hampering the access of the synthetic glucocorticoid, prednisolone. In vivo, a tracer dose of [(3)H]prednisolone poorly penetrated the brain of adrenalectomised wild-type mice, but the uptake was more than threefold enhanced in the absence of Pgp expression in mdr1a (-/-) mice. In vitro, in stably transfected LLC-PK1 monolayers the human MDR1 P-glycoprotein was able to transport prednisolone present at a micromolar concentration. A specific Pgp blocker, LY 335979, could block this polar transport of [(3)H]prednisolone. Human Pgp does not transport all steroids, as cortexolone was not transported at all and aldosterone was only weakly transported. The ability of Pgp to export the synthetic glucocorticoid, prednisolone, suggests that uptake of prednisolone in the human brain is impaired, leading to a discrepancy between central and peripheral actions. Furthermore, the ensuing imbalance in activation of the two types of brain corticosteroid receptors may have consequences for cognitive performance and mood.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
A. Viana, S. Rates, B. Naudin, F. Janin, J. Costentin, and J-C. do Rego
Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels
J Psychopharmacol, August 1, 2008; 22(6): 681 - 690.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
B. D. Anderson, M. J. May, S. Jordan, L. Song, M. J. Roberts, and M. Leggas
DEPENDENCE OF NELFINAVIR BRAIN UPTAKE ON DOSE AND TISSUE CONCENTRATIONS OF THE SELECTIVE P-GLYCOPROTEIN INHIBITOR ZOSUQUIDAR IN RATS
Drug Metab. Dispos., April 1, 2006; 34(4): 653 - 659.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Sahasranaman, M. Issar, and G. Hochhaus
METABOLISM OF MOMETASONE FUROATE AND BIOLOGICAL ACTIVITY OF THE METABOLITES
Drug Metab. Dispos., February 1, 2006; 34(2): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. M. Karssen, O. C. Meijer, A. Berry, R. Sanjuan Pinol, and E. R. de Kloet
Low Doses of Dexamethasone Can Produce a Hypocorticosteroid State in the Brain
Endocrinology, December 1, 2005; 146(12): 5587 - 5595.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Pavek, G. Merino, E. Wagenaar, E. Bolscher, M. Novotna, J. W. Jonker, and A. H. Schinkel
Human Breast Cancer Resistance Protein: Interactions with Steroid Drugs, Hormones, the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and Transport of Cimetidine
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 144 - 152.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M. T. Grauer and M. Uhr
P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline
J Psychopharmacol, March 1, 2004; 18(1): 66 - 74.
[Abstract] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Endocrinology.